MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
2. Industry_Business Architects & Consolidators
Industry: By Region (Globally)
Industry: International
Industry: Australia
PYC THERAPEUTICS
Attachments
PYC Therapeutics
Parents
*Architects: Biotechnology_DNA, RNA, RNAi, siRNA & mRNA
*Architects: Biotechnology_Peptides
*Architects: Drug Delivery
Extraordinary Corporate Investments, and/or Multiple Strategics
Industry: Australia
Children
Founded 2001
Phylomer drug discovery platform for peptide-based drug discovery.
PYC Therapeutics (ASX: PYC) is a development-stage biotechnology company pioneering a new generation of RNA therapeutics that utilize Cell Penetrating Peptides (CPPs), a revolutionary delivery technology designed to overcome the major challenges of current gene-based therapies.
Sahm Nasseri CEO, PYC THERAPEUTICS (2021)
With the present announcement, Phylogica has now entered into three alliances with global pharmaceutical companies within the last 12 months (2010)
Jumps
F. Hoffmann-La Roche Holding Ltd (RHHBF; RHHBY)
Johnson & Johnson, Inc. [J&J] (NYSE:JNJ)*
MedImmune, Inc (MEDI)
Pfizer Inc. (NYSE: PFE)